SEC Form 4 · accession 0001144204-16-111978
Cellectar Biosciences, Inc. · CLRB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stefan Loren
Director
Period of report
Jul 5, 2016
Accepted (ET)
Jul 7, 2016 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001279704
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy) | $3.34 | Jul 5, 2016 | A | 22,500 | A | Jul 5, 2017 | Jul 5, 2026 | Common Stock | 22,500 | 23,500 | D |